BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with an IC50 of 64 nM for MRCKbeta in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKalpha/beta in house determinations, respectively. BDP9066 has therapeut
Molecular Weight:
348.44
Purity:
98.49
CAS Number:
[2226507-04-4]
Formula:
C20H24N6
Target:
Ras
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted